MD Anderson research shows modern chemotherapies are tied to a small but significant increased risk of secondary MDS and AML in older breast cancer patients. These findings may help oncologists understand their patients’ risks and better inform discussions with them.
Cancer drug shortage: Price gouging of chemo drugs hits some
Alternatives to chemotherapy: 5 options
New research could overcome drug resistance in acute myeloid
Chemotherapy at home: 9 things to know
White Blood Cell Count and Cancer: What You Should Know
Chemotherapy sometimes set the stage for drug-resistant leukemia
New drug combo shows promise against prostate cancer in trials
Blood Cancers Overview - History, Advancements and Challenges
How does leukemia affect the body? Symptoms and impact
Mitigating long-term and delayed adverse events associated with
What to Know About Rising Rates of 'Early-Onset' Cancer > News
Leukemia: Causes and Risk Factors